Emerging treatments for hypertension: potential role for vasopeptidase inhibition.

Emerging treatments for hypertension: potential role for vasopeptidase inhibition.

Item
http://www.wikidata.org/entity/Q33793511
The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy.Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity.Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic ratsProteinase activity regulation by glycosaminoglycans.Role of bradykinin in preconditioning and protection of the ischaemic myocardium.Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complicationsEffect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice.Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunctionVascular and neural dysfunctions in obese Zucker rats: effect of AVE7688.Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.A double-blind, placebo-controlled study to assess tolerability, pharmacokinetics and preliminary pharmacodynamics of single escalating doses of Z13752A, a novel dual inhibitor of the metalloproteases ACE and NEP, in healthy volunteersEffects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease.An overview of antihypertensive therapy in the 20th century.
P2860

Emerging treatments for hypertension: potential role for vasopeptidase inhibition.

Item
http://www.wikidata.org/entity/Q33793511
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Emerging treatments for hypertension: potential role for vasopeptidase inhibition.
@ast
Emerging treatments for hypertension: potential role for vasopeptidase inhibition.
@en
type
label
Emerging treatments for hypertension: potential role for vasopeptidase inhibition.
@ast
Emerging treatments for hypertension: potential role for vasopeptidase inhibition.
@en
prefLabel
Emerging treatments for hypertension: potential role for vasopeptidase inhibition.
@ast
Emerging treatments for hypertension: potential role for vasopeptidase inhibition.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Emerging treatments for hypertension: potential role for vasopeptidase inhibition.
@en
P2093
P304
P31
P356
10.1016/S0895-7061(99)00205-8
P433
P478
P577
P698